A BILL 
To amend the Public Health Service Act (42 U.S.C. 201 
et seq.) to authorize funding for maternal mortality re-
view committees to promote representative community 
engagement, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
22:40 Mar 04, 2021
H925
2 
•HR 925 IH
SECTION 1. SHORT TITLE. 
1
This Act may be cited as the ‘‘Data to Save Moms 
2
Act’’. 
3
SEC. 2. FUNDING FOR MATERNAL MORTALITY REVIEW 
4
COMMITTEES TO PROMOTE REPRESENTA-
5
TIVE COMMUNITY ENGAGEMENT. 
6
(a) IN GENERAL.—Section 317K(d) of the Public 
7
Health Service Act (42 U.S.C. 247b–12(d)) is amended 
8
by adding at the end the following: 
9
‘‘(9) GRANTS
TO
PROMOTE
REPRESENTATIVE 
10
COMMUNITY
ENGAGEMENT
IN
MATERNAL
MOR-
11
TALITY REVIEW COMMITTEES.— 
12
‘‘(A) IN
GENERAL.—The Secretary may, 
13
using funds made available pursuant to sub-
14
paragraph (C), provide assistance to an applica-
15
ble maternal mortality review committee of a 
16
State, Indian tribe, tribal organization, or 
17
urban Indian organization (as such term is de-
18
fined in section 4 of the Indian Health Care 
19
Improvement Act (25 U.S.C. 1603))— 
20
‘‘(i) to select for inclusion in the mem-
21
bership of such a committee community 
22
members from the State, Indian tribe, trib-
23
al organization, or urban Indian organiza-
24
tion by— 
25
22:40 Mar 04, 2021
H925
3 
•HR 925 IH
‘‘(I) prioritizing community mem-
1
bers who can increase the diversity of 
2
the committee’s membership with re-
3
spect to race and ethnicity, location, 
4
and professional background, includ-
5
ing members with non-clinical experi-
6
ences; and 
7
‘‘(II) to the extent applicable, 
8
using funds reserved under subsection 
9
(f), to address barriers to maternal 
10
mortality review committee participa-
11
tion for community members, includ-
12
ing required training, transportation 
13
barriers, compensation, and other sup-
14
ports as may be necessary; 
15
‘‘(ii) to establish initiatives to conduct 
16
outreach and community engagement ef-
17
forts within communities throughout the 
18
State or Tribe to seek input from commu-
19
nity members on the work of such mater-
20
nal mortality review committee, with a par-
21
ticular focus on outreach to minority 
22
women; and 
23
‘‘(iii) to release public reports assess-
24
ing— 
25
22:40 Mar 04, 2021
H925
4 
•HR 925 IH
‘‘(I) the pregnancy-related death 
1
and pregnancy-associated death review 
2
processes of the maternal mortality 
3
review committee, with a particular 
4
focus on the maternal mortality re-
5
view committee’s sensitivity to the 
6
unique circumstances of pregnant and 
7
postpartum individuals from racial 
8
and ethnic minority groups (as such 
9
term is defined in section 1707(g)(1)) 
10
who have suffered pregnancy-related 
11
deaths; and 
12
‘‘(II) the impact of the use of 
13
funds made available pursuant to 
14
paragraph (C) on increasing the diver-
15
sity of the maternal mortality review 
16
committee membership and promoting 
17
community 
engagement 
efforts 
18
throughout the State or Tribe. 
19
‘‘(B) TECHNICAL ASSISTANCE.—The Sec-
20
retary shall provide (either directly through the 
21
Department of Health and Human Services or 
22
by contract) technical assistance to any mater-
23
nal mortality review committee receiving a 
24
grant under this paragraph on best practices 
25
22:40 Mar 04, 2021
H925
5 
•HR 925 IH
for increasing the diversity of the maternal 
1
mortality review committee’s membership and 
2
for conducting effective community engagement 
3
throughout the State or Tribe. 
4
‘‘(C) 
AUTHORIZATION
OF
APPROPRIA-
5
TIONS.—In addition to any funds made avail-
6
able under subsection (f), there are authorized 
7
to be appropriated to carry out this paragraph 
8
$10,000,000 for each of fiscal years 2022 
9
through 2026.’’. 
10
(b) RESERVATION OF FUNDS.—Section 317K(f) of 
11
the Public Health Service Act (42 U.S.C. 247b–12(f)) is 
12
amended by adding at the end the following: ‘‘Of the 
13
amount made available under the preceding sentence for 
14
a fiscal year, not less than $1,500,000 shall be reserved 
15
for grants to Indian tribes, tribal organizations, or urban 
16
Indian organizations (as those terms are defined in section 
17
4 of the Indian Health Care Improvement Act (25 U.S.C. 
18
1603))’’. 
19
SEC. 3. DATA COLLECTION AND REVIEW. 
20
Section 317K(d)(3)(A)(i) of the Public Health Serv-
21
ice Act (42 U.S.C. 247b–12(d)(3)(A)(i)) is amended— 
22
(1) by redesignating subclauses (II) and (III) 
23
as subclauses (V) and (VI), respectively; and 
24
22:40 Mar 04, 2021
H925
6 
•HR 925 IH
(2) by inserting after subclause (I) the fol-
1
lowing: 
2
‘‘(II) to the extent practicable, 
3
reviewing cases of severe maternal 
4
morbidity, according to the most up- 
5
to-date indicators; 
6
‘‘(III) to the extent practicable, 
7
reviewing deaths during pregnancy or 
8
up to 1 year after the end of a preg-
9
nancy from suicide, overdose, or other 
10
death from a mental health condition 
11
or substance use disorder attributed 
12
to or aggravated by pregnancy or 
13
childbirth complications; 
14
‘‘(IV) to the extent practicable, 
15
consulting with local community-based 
16
organizations representing pregnant 
17
and postpartum individuals from de-
18
mographic groups disproportionately 
19
impacted by poor maternal health out-
20
comes to ensure that, in addition to 
21
clinical factors, non-clinical factors 
22
that might have contributed to a preg-
23
nancy-related death are appropriately 
24
considered;’’. 
25
22:40 Mar 04, 2021
H925
7 
•HR 925 IH
SEC. 4. REVIEW OF MATERNAL HEALTH DATA COLLECTION 
1
PROCESSES AND QUALITY MEASURES. 
2
(a) IN GENERAL.—The Secretary of Health and 
3
Human Services, acting through the Administrator for 
4
Centers for Medicare & Medicaid Serves and the Director 
5
of the Agency for Healthcare Research and Quality, shall 
6
consult with relevant stakeholders— 
7
(1) to review existing maternal health data col-
8
lection processes and quality measures; and 
9
(2) make recommendations to improve such 
10
processes and measures, including topics described 
11
under subsection (c). 
12
(b) COLLABORATION.—In carrying out this section, 
13
the Secretary shall consult with a diverse group of mater-
14
nal health stakeholders, which may include— 
15
(1) pregnant and postpartum individuals and 
16
their family members, and non-profit organizations 
17
representing such individuals, with a particular focus 
18
on patients from racial and ethnic minority groups; 
19
(2) community-based organizations that provide 
20
support for pregnant and postpartum individuals, 
21
with a particular focus on patients from racial and 
22
ethnic minority groups; 
23
(3) membership organizations for maternity 
24
care providers; 
25
22:40 Mar 04, 2021
H925
8 
•HR 925 IH
(4) organizations representing perinatal health 
1
workers; 
2
(5) organizations that focus on maternal mental 
3
or behavioral health; 
4
(6) organizations that focus on intimate partner 
5
violence; 
6
(7) institutions of higher education, with a par-
7
ticular focus on minority-serving institutions; 
8
(8) licensed and accredited hospitals, birth cen-
9
ters, midwifery practices, or other medical practices 
10
that provide maternal health care services to preg-
11
nant and postpartum patients; 
12
(9) relevant State and local public agencies, in-
13
cluding State maternal mortality review committees; 
14
and 
15
(10) the National Quality Forum, or such other 
16
standard-setting organizations specified by the Sec-
17
retary. 
18
(c) TOPICS.—The review of maternal health data col-
19
lection processes and recommendations to improve such 
20
processes and measures required under subsection (a) 
21
shall assess all available relevant information, including 
22
information from State-level sources, and shall consider at 
23
least the following: 
24
22:40 Mar 04, 2021
H925
9 
•HR 925 IH
(1) Current State and Tribal practices for ma-
1
ternal health, maternal mortality, and severe mater-
2
nal morbidity data collection and dissemination, in-
3
cluding consideration of— 
4
(A) the timeliness of processes for amend-
5
ing a death certificate when new information 
6
pertaining to the death becomes available to re-
7
flect whether the death was a pregnancy-related 
8
death; 
9
(B) relevant data collected with electronic 
10
health records, including data on race, eth-
11
nicity, socioeconomic status, insurance type, 
12
and other relevant demographic information; 
13
(C) maternal health data collected and 
14
publicly reported by hospitals, health systems, 
15
midwifery practices, and birth centers; 
16
(D) the barriers preventing States from 
17
correlating maternal outcome data with race 
18
and ethnicity data; 
19
(E) processes for determining the cause of 
20
a pregnancy-associated death in States that do 
21
not have a maternal mortality review com-
22
mittee; 
23
(F) whether maternal mortality review 
24
committees include multidisciplinary and di-
25
22:40 Mar 04, 2021
H925
10 
•HR 925 IH
verse membership (as described in section 
1
317K(d)(1)(A) of the Public Health Service Act 
2
(42 U.S.C. 247b–12(d)(1)(A))); 
3
(G) whether members of maternal mor-
4
tality review committees participate in trainings 
5
on bias, racism, or discrimination, and the qual-
6
ity of such trainings; 
7
(H) the extent to which States have imple-
8
mented systematic processes of listening to the 
9
stories of pregnant and postpartum individuals 
10
and their family members, with a particular 
11
focus on pregnant and postpartum individuals 
12
from racial and ethnic minority groups (as such 
13
term is defined in section 1707(g)(1) of the 
14
Public Health Service Act (42 U.S.C. 300u– 
15
6(g)(1))) and their family members, to fully un-
16
derstand the causes of, and inform potential so-
17
lutions to, the maternal mortality and severe 
18
maternal morbidity crisis within their respective 
19
States; 
20
(I) the extent to which maternal mortality 
21
review committees are considering social deter-
22
minants of maternal health when examining the 
23
causes of pregnancy-associated and pregnancy- 
24
related deaths; 
25
22:40 Mar 04, 2021
H925
11 
•HR 925 IH
(J) the extent to which maternal mortality 
1
review committees are making actionable rec-
2
ommendations based on their reviews of adverse 
3
maternal health outcomes and the extent to 
4
which such recommendations are being imple-
5
mented by appropriate stakeholders; 
6
(K) the legal and administrative barriers 
7
preventing the collection, collation, and dissemi-
8
nation of State maternity care data; 
9
(L) the effectiveness of data collection and 
10
reporting processes in separating pregnancy-as-
11
sociated deaths from pregnancy-related deaths; 
12
(M) the current Federal, State, local, and 
13
Tribal funding support for the activities re-
14
ferred to in subparagraphs (A) through (L). 
15
(2) Whether the funding support referred to in 
16
paragraph (1)(M) is adequate for States to carry out 
17
optimal data collection and dissemination processes 
18
with respect to maternal health, maternal mortality, 
19
and severe maternal morbidity. 
20
(3) Current quality measures for maternity 
21
care, including prenatal measures, labor and delivery 
22
measures, and postpartum measures, including top-
23
ics such as— 
24
22:40 Mar 04, 2021
H925
12 
•HR 925 IH
(A) effective quality measures for mater-
1
nity care used by hospitals, health systems, 
2
midwifery practices, birth centers, health plans, 
3
and other relevant entities; 
4
(B) the sufficiency of current outcome 
5
measures used to evaluate maternity care for 
6
driving improved care, experiences, and out-
7
comes in maternity care payment and delivery 
8
system models; 
9
(C) maternal health quality measures that 
10
other countries effectively use; 
11
(D) validated measures that have been 
12
used for research purposes that could be tested, 
13
refined, and submitted for national endorse-
14
ment; 
15
(E) barriers preventing maternity care pro-
16
viders and insurers from implementing quality 
17
measures that are aligned with best practices; 
18
(F) the frequency with which maternity 
19
care quality measures are reviewed and revised; 
20
(G) the strengths and weaknesses of the 
21
Prenatal and Postpartum Care measures of the 
22
Health Plan Employer Data and Information 
23
Set measures established by the National Com-
24
mittee for Quality Assurance; 
25
22:40 Mar 04, 2021
H925
13 
•HR 925 IH
(H) the strengths and weaknesses of ma-
1
ternity care quality measures under the Med-
2
icaid program under title XIX of the Social Se-
3
curity Act (42 U.S.C. 1396 et seq.) and the 
4
Children’s Health Insurance Program under 
5
title XXI of such Act (42 U.S.C. 1397 et seq.), 
6
including the extent to which States voluntarily 
7
report relevant measures; 
8
(I) the extent to which maternity care 
9
quality measures are informed by patient expe-
10
riences that include measures of patient-re-
11
ported experience of care; 
12
(J) the current processes for collecting 
13
stratified data on the race and ethnicity of 
14
pregnant and postpartum individuals in hos-
15
pitals, health systems, midwifery practices, and 
16
birth centers, and for incorporating such ra-
17
cially and ethnically stratified data in maternity 
18
care quality measures; 
19
(K) the extent to which maternity care 
20
quality measures account for the unique experi-
21
ences of pregnant and postpartum individuals 
22
from racial and ethnic minority groups (as such 
23
term is defined in section 1707(g)(1) of the 
24
22:40 Mar 04, 2021
H925
14 
•HR 925 IH
Public Health Service Act (42 U.S.C. 300u– 
1
6(g)(1))); and 
2
(L) the extent to which hospitals, health 
3
systems, midwifery practices, and birth centers 
4
are implementing existing maternity care qual-
5
ity measures. 
6
(4) Recommendations on authorizing additional 
7
funds and providing additional technical assistance 
8
to improve maternal mortality review committees 
9
and State and Tribal maternal health data collection 
10
and reporting processes. 
11
(5) Recommendations for new authorities that 
12
may be granted to maternal mortality review com-
13
mittees to be able to— 
14
(A) access records from other Federal and 
15
State agencies and departments that may be 
16
necessary to identify causes of pregnancy-asso-
17
ciated and pregnancy-related deaths that are 
18
unique to pregnant and postpartum individuals 
19
from specific populations, such as veterans and 
20
individuals who are incarcerated; and 
21
(B) work with relevant experts who are not 
22
members of the maternal mortality review com-
23
mittee to assist in the review of pregnancy-asso-
24
ciated deaths of pregnant and postpartum indi-
25
22:40 Mar 04, 2021
H925
15 
•HR 925 IH
viduals from specific populations, such as vet-
1
erans and individuals who are incarcerated. 
2
(6) Recommendations to improve and stand-
3
ardize current quality measures for maternity care, 
4
with a particular focus on racial and ethnic dispari-
5
ties in maternal health outcomes. 
6
(7) Recommendations to improve the coordina-
7
tion by the Department of Health and Human Serv-
8
ices of the efforts undertaken by the agencies and 
9
organizations within the Department related to ma-
10
ternal health data and quality measures. 
11
(d) REPORT.—Not later than 1 year after the enact-
12
ment of this Act, the Secretary shall submit to the Con-
13
gress and make publicly available a report on the results 
14
of the review of maternal health data collection processes 
15
and quality measures and recommendations to improve 
16
such processes and measures required under subsection 
17
(a). 
18
(e) DEFINITIONS.—In this section: 
19
(1) MATERNAL
MORTALITY
REVIEW
COM-
20
MITTEE.—The term ‘‘maternal mortality review 
21
committee’’ means a maternal mortality review com-
22
mittee duly authorized by a State and receiving 
23
funding under section 317k(a)(2)(D) of the Public 
24
Health Service Act (42 U.S.C. 247b–12(a)(2)(D)). 
25
22:40 Mar 04, 2021
H925
16 
•HR 925 IH
(2) 
PREGNANCY-ASSOCIATED
DEATH.—The 
1
term ‘‘pregnancy-associated’’, with respect to a 
2
death, means a death of a pregnant or postpartum 
3
individual, by any cause, that occurs during, or with-
4
in 1 year following, the individual’s pregnancy, re-
5
gardless of the outcome, duration, or site of the 
6
pregnancy. 
7
(3) PREGNANCY-RELATED
DEATH.—The term 
8
‘‘pregnancy-related’’, with respect to a death, means 
9
a death of a pregnant or postpartum individual that 
10
occurs during, or within 1 year following, the indi-
11
vidual’s pregnancy, from a pregnancy complication, 
12
a chain of events initiated by pregnancy, or the ag-
13
gravation of an unrelated condition by the physio-
14
logic effects of pregnancy. 
15
(f) AUTHORIZATION
OF APPROPRIATIONS.—There 
16
are authorized to be appropriated such sums as may be 
17
necessary to carry out this section for fiscal years 2022 
18
through 2025. 
19
SEC. 5. INDIAN HEALTH SERVICE STUDY ON MATERNAL 
20
MORTALITY AND SEVERE MATERNAL MOR-
21
BIDITY. 
22
(a) IN GENERAL.—The Director of the Indian Health 
23
Service (referred to in this section as the ‘‘Director’’) 
24
22:40 Mar 04, 2021
H925
17 
•HR 925 IH
shall, in coordination with entities described in subsection 
1
(b)— 
2
(1) not later than 90 days after the enactment 
3
of this Act, enter into a contract with an inde-
4
pendent research organization or Tribal Epidemi-
5
ology Center to conduct a comprehensive study on 
6
maternal mortality and severe maternal morbidity in 
7
the populations of American Indian and Alaska Na-
8
tive individuals; and 
9
(2) not later than 3 years after the date of the 
10
enactment of this Act, submit to Congress a report 
11
on such study that contains recommendations for 
12
policies and practices that can be adopted to im-
13
prove maternal health outcomes for pregnant and 
14
postpartum American Indian and Alaska Native in-
15
dividuals. 
16
(b) PARTICIPATING
ENTITIES.—The entities de-
17
scribed in this subsection shall consist of 12 members, se-
18
lected by the Director from among individuals nominated 
19
by Indian tribes and tribal organizations (as such terms 
20
are defined in section 4 of the Indian Self-Determination 
21
and Education Assistance Act (25 U.S.C. 5304)), and 
22
urban Indian organizations (as such term is defined in 
23
section 4 of the Indian Health Care Improvement Act (25 
24
U.S.C. 1603)). In selecting such members, the Director 
25
22:40 Mar 04, 2021
H925
18 
•HR 925 IH
shall ensure that each of the 12 service areas of the Indian 
1
Health Service is represented. 
2
(c) CONTENTS
OF STUDY.—The study conducted 
3
pursuant to subsection (a) shall— 
4
(1) examine the causes of maternal mortality 
5
and severe maternal morbidity that are unique to 
6
American Indian and Alaska Native individuals; 
7
(2) include a systematic process of listening to 
8
the stories of American Indian and Alaska Native 
9
pregnant and postpartum individuals to fully under-
10
stand the causes of, and inform potential solutions 
11
to, the maternal mortality and severe maternal mor-
12
bidity crisis within their respective communities; 
13
(3) distinguish between the causes of, landscape 
14
of maternity care at, and recommendations to im-
15
prove maternal health outcomes within, the different 
16
settings in which American Indian and Alaska Na-
17
tive pregnant and postpartum individuals receive 
18
maternity care, such as— 
19
(A) facilities operated by the Indian 
20
Health Service; 
21
(B) an Indian health program operated by 
22
an Indian tribe or tribal organization pursuant 
23
to a contract, grant, cooperative agreement, or 
24
22:40 Mar 04, 2021
H925
19 
•HR 925 IH
compact with the Indian Health Service pursu-
1
ant to the Indian Self-Determination Act; and 
2
(C) an urban Indian health program oper-
3
ated by an urban Indian organization pursuant 
4
to a grant or contract with the Indian Health 
5
Service pursuant to title V of the Indian Health 
6
Care Improvement Act; 
7
(4) review processes for coordinating programs 
8
of the Indian Health Service with social services pro-
9
vided through other programs administered by the 
10
Secretary of Health and Human Services (other 
11
than the Medicare program under title XVIII of the 
12
Social Security Act, the Medicaid program under 
13
title XIX of such Act, and the Children’s Health In-
14
surance Program under title XXI of such Act); 
15
(5) review current data collection and quality 
16
measurement processes and practices; 
17
(6) assess causes and frequency of maternal 
18
mental health conditions and substance use dis-
19
orders; 
20
(7) consider social determinants of health, in-
21
cluding poverty, lack of health insurance, unemploy-
22
ment, sexual violence, and environmental conditions 
23
in Tribal areas; 
24
22:40 Mar 04, 2021
H925
20 
•HR 925 IH
(8) consider the role that historical mistreat-
1
ment of American Indian and Alaska Native women 
2
has played in causing currently high rates of mater-
3
nal mortality and severe maternal morbidity; 
4
(9) consider how current funding of the Indian 
5
Health Service affects the ability of the Service to 
6
deliver quality maternity care; 
7
(10) consider the extent to which the delivery of 
8
maternity care services is culturally appropriate for 
9
American Indian and Alaska Native pregnant and 
10
postpartum individuals; 
11
(11) make recommendations to reduce misclass-
12
ification of American Indian and Alaska Native 
13
pregnant and postpartum individuals, including con-
14
sideration of best practices in training for maternal 
15
mortality review committee members to be able to 
16
correctly classify American Indian and Alaska Na-
17
tive individuals; and 
18
(12) make recommendations informed by the 
19
stories shared by American Indian and Alaska Na-
20
tive pregnant and postpartum individuals in para-
21
graph (2) to improve maternal health outcomes for 
22
such individuals. 
23
(d) REPORT.—The agreement entered into under 
24
subsection (a) with an independent research organization 
25
22:40 Mar 04, 2021
H925
21 
•HR 925 IH
or Tribal Epidemiology Center shall require that the orga-
1
nization or center transmit to Congress a report on the 
2
results of the study conducted pursuant to that agreement 
3
not later than 36 months after the date of the enactment 
4
of this Act. 
5
(e) AUTHORIZATION OF APPROPRIATIONS.—There is 
6
authorized to be appropriated to carry out this section 
7
$2,000,000 for each of fiscal years 2022 through 2024. 
8
SEC. 6. GRANTS TO MINORITY-SERVING INSTITUTIONS TO 
9
STUDY MATERNAL MORTALITY, SEVERE MA-
10
TERNAL MORBIDITY, AND OTHER ADVERSE 
11
MATERNAL HEALTH OUTCOMES. 
12
(a) IN GENERAL.—The Secretary of Health and 
13
Human Services shall establish a program under which 
14
the Secretary shall award grants to research centers, 
15
health professions schools and programs, and other enti-
16
ties at minority-serving institutions to study specific as-
17
pects of the maternal health crisis among pregnant and 
18
postpartum individuals from racial and ethnic minority 
19
groups. Such research may— 
20
(1) include the development and implementation 
21
of systematic processes of listening to the stories of 
22
pregnant and postpartum individuals from racial 
23
and ethnic minority groups, and perinatal health 
24
workers supporting such individuals, to fully under-
25
22:40 Mar 04, 2021
H925
22 
•HR 925 IH
stand the causes of, and inform potential solutions 
1
to, the maternal mortality and severe maternal mor-
2
bidity crisis within their respective communities; 
3
(2) assess the potential causes of relatively low 
4
rates of maternal mortality among Hispanic individ-
5
uals, including potential racial misclassification and 
6
other data collection and reporting issues that might 
7
be misrepresenting maternal mortality rates among 
8
Hispanic individuals in the United States; and 
9
(3) assess differences in rates of adverse mater-
10
nal health outcomes among subgroups identifying as 
11
Hispanic. 
12
(b) APPLICATION.—To be eligible to receive a grant 
13
under subsection (a), an entity described in such sub-
14
section shall submit to the Secretary an application at 
15
such time, in such manner, and containing such informa-
16
tion as the Secretary may require. 
17
(c) TECHNICAL ASSISTANCE.—The Secretary may 
18
use not more than 10 percent of the funds made available 
19
under subsection (f)— 
20
(1) to conduct outreach to Minority-Serving In-
21
stitutions to raise awareness of the availability of 
22
grants under this subsection (a); 
23
(2) to provide technical assistance in the appli-
24
cation process for such a grant; and 
25
22:40 Mar 04, 2021
H925
23 
•HR 925 IH
(3) to promote capacity building as needed to 
1
enable entities described in such subsection to sub-
2
mit such an application. 
3
(d) REPORTING REQUIREMENT.—Each entity award-
4
ed a grant under this section shall periodically submit to 
5
the Secretary a report on the status of activities conducted 
6
using the grant. 
7
(e) EVALUATION.—Beginning one year after the date 
8
on which the first grant is awarded under this section, 
9
the Secretary shall submit to Congress an annual report 
10
summarizing the findings of research conducted using 
11
funds made available under this section. 
12
(f) MINORITY-SERVING INSTITUTIONS DEFINED.—In 
13
this section, the term ‘‘minority-serving institution’’ has 
14
the meaning given the term in section 371(a) of the High-
15
er Education Act of 1965 (20 U.S.C. 1067q(a)). 
16
(g) AUTHORIZATION
OF APPROPRIATIONS.—There 
17
are authorized to be appropriated to carry out this section 
18
$10,000,000 for each of fiscal years 2022 through 2026. 
19
SEC. 7. DEFINITIONS. 
20
In this Act: 
21
(1) CULTURALLY CONGRUENT.—The term ‘‘cul-
22
turally congruent’’, with respect to care or maternity 
23
care, means care that is in agreement with the pre-
24
ferred cultural values, beliefs, worldview, language, 
25
22:40 Mar 04, 2021
H925
24 
•HR 925 IH
and practices of the health care consumer and other 
1
stakeholders. 
2
(2) MATERNITY
CARE
PROVIDER.—The term 
3
‘‘maternity care provider’’ means a health care pro-
4
vider who— 
5
(A) is a physician, physician assistant, 
6
midwife who meets at a minimum the inter-
7
national definition of the midwife and global 
8
standards for midwifery education as estab-
9
lished by the International Confederation of 
10
Midwives, nurse practitioner, or clinical nurse 
11
specialist; and 
12
(B) has a focus on maternal or perinatal 
13
health. 
14
(3) MATERNAL MORTALITY.—The term ‘‘mater-
15
nal mortality’’ means a death occurring during or 
16
within a one-year period after pregnancy, caused by 
17
pregnancy-related or childbirth complications, in-
18
cluding a suicide, overdose, or other death resulting 
19
from a mental health or substance use disorder at-
20
tributed to or aggravated by pregnancy-related or 
21
childbirth complications. 
22
(4) PERINATAL HEALTH WORKER.—The term 
23
‘‘perinatal health worker’’ means a doula, commu-
24
nity health worker, peer supporter, breastfeeding 
25
22:40 Mar 04, 2021
H925
25 
•HR 925 IH
and lactation educator or counselor, nutritionist or 
1
dietitian, childbirth educator, social worker, home 
2
visitor, language interpreter, or navigator. 
3
(5) POSTPARTUM AND POSTPARTUM PERIOD.— 
4
The terms ‘‘postpartum’’ and ‘‘postpartum period’’ 
5
refer to the 1-year period beginning on the last day 
6
of the pregnancy of an individual. 
7
(6) 
PREGNANCY-ASSOCIATED
DEATH.—The 
8
term ‘‘pregnancy-associated death’’ means a death of 
9
a pregnant or postpartum individual, by any cause, 
10
that occurs during, or within 1 year following, the 
11
individual’s pregnancy, regardless of the outcome, 
12
duration, or site of the pregnancy. 
13
(7) PREGNANCY-RELATED
DEATH.—The term 
14
‘‘pregnancy-related death’’ means a death of a preg-
15
nant or postpartum individual that occurs during, or 
16
within 1 year following, the individual’s pregnancy, 
17
from a pregnancy complication, a chain of events 
18
initiated by pregnancy, or the aggravation of an un-
19
related condition by the physiologic effects of preg-
20
nancy. 
21
(8) RACIAL AND ETHNIC MINORITY GROUP.— 
22
The term ‘‘racial and ethnic minority group’’ has the 
23
meaning given such term in section 1707(g)(1) of 
24
22:40 Mar 04, 2021
H925
26 
•HR 925 IH
the Public Health Service Act (42 U.S.C. 300u– 
1
6(g)(1)). 
2
(9) SEVERE MATERNAL MORBIDITY.—The term 
3
‘‘severe maternal morbidity’’ means a health condi-
4
tion, including mental health conditions and sub-
5
stance use disorders, attributed to or aggravated by 
6
pregnancy or childbirth that results in significant 
7
short-term or long-term consequences to the health 
8
of the individual who was pregnant. 
9
(10) SOCIAL
DETERMINANTS
OF
MATERNAL 
10
HEALTH DEFINED.—The term ‘‘social determinants 
11
of maternal health’’ means non-clinical factors that 
12
impact maternal health outcomes, including— 
13
(A) economic factors, which may include 
14
poverty, employment, food security, support for 
15
and access to lactation and other infant feeding 
16
options, housing stability, and related factors; 
17
(B) neighborhood factors, which may in-
18
clude quality of housing, access to transpor-
19
tation, access to child care, availability of 
20
healthy foods and nutrition counseling, avail-
21
ability of clean water, air and water quality, 
22
ambient temperatures, neighborhood crime and 
23
violence, access to broadband, and related fac-
24
tors; 
25
22:40 Mar 04, 2021
H925
27 
•HR 925 IH
(C) social and community factors, which 
1
may include systemic racism, gender discrimi-
2
nation or discrimination based on other pro-
3
tected classes, workplace conditions, incarcer-
4
ation, and related factors; 
5
(D) household factors, which may include 
6
ability to conduct lead testing and abatement, 
7
car seat installation, indoor air temperatures, 
8
and related factors; 
9
(E) education access and quality factors, 
10
which may include educational attainment, lan-
11
guage and literacy, and related factors; and 
12
(F) health care access factors, including 
13
health insurance coverage, access to culturally 
14
congruent health care services, providers, and 
15
non-clinical support, access to home visiting 
16
services, access to wellness and stress manage-
17
ment programs, health literacy, access to tele-
18
health and items required to receive telehealth 
19
services, and related factors. 
20
Æ 
22:40 Mar 04, 2021
H925
